Provider profile
Cytel.
Clinical biometrics
Cytel describes end-to-end biometrics services: biostatistics, statistical analysis plans and programming, clinical data management and database design, CDISC SDTM/ADaM work, ISS/ISE and data submission support, adaptive designs and data monitoring committee support across Phases I–IV. It offers FSP and hybrid models and lists headquarters in Cambridge, Massachusetts, with offices in Europe, India, Canada and China.
- Website
- cytel.com (opens in a new tab)
- Sources reviewed
- November 3, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
Development experience
Locations
Locations
- Cambridge, United States · Headquarters11
- Vancouver, Canada · Office11
- Shanghai, China · Office11
- Paris, France · Office11
- Hyderabad, India · Office11
- Pune, India · Office11Described by the company as its India headquarters
- Rotterdam, Netherlands · Office11
- Basel, Switzerland · Office11
- Geneva, Switzerland · Office11
- London, United Kingdom · Office11
- Seattle, United States · Office11
Quality and regulatory
Quality and regulatory
No quality framework or accreditation is established from reviewed sources. Ask for current certificates and recent inspection history.
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Named statistician and programming lead for your study, and their recent experience in your indication
- Current capacity and realistic start date for database build and SAP authoring
- Which CDISC standard versions and FDA Data Standards Catalog requirements they will deliver against
- EDC system(s) supported and who holds the licence
- Assumptions behind the budget: number of TLFs, interim analyses, DMC meetings and data transfers
- How change orders are triggered and priced
Not established from reviewed sources: platforms and methods, quality frameworks (vendor-reported).
Evidence and sources
Evidence and sources
- 1Adaptive Clinical Trial Designs | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Functional Service Provider (FSP) Solutions | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Clinical Data Management Services | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Data Submission Support | Clinical Compliance | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5End to End Clinical Biometrics | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Hybrid FSP Model | Functional Service Provider | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7Early Phase Clinical Trial Services | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8Cytel | Clinical Research Organization | Software & Data Analysis (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Late Phase Clinical Trial Services | Cytel (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 10Clinical Trial Specialty Areas | Drug Development Solutions (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 11Contact Cytel | Clinical Trial & Data Analysis Company (opens in a new tab)Cytel · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.